Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie 1981-06-01

Factor XII assay with the chromogenic substrate chromozym PK.

W Dick, W Cullmann, N Müller, K Adler

Index: J. Clin. Chem. Clin. Biochem. 19(6) , 357-61, (1981)

Full Text: HTML

Abstract

A chromogenic assay for the determination of factor XII using the chromogenic substrate Chromozym PK was evaluated. The assay was linear in the range 10 U/l to more than 200 U/l. Using the assay, the normal range of factor XII (50 healthy volunteers at random) was 136 U/l +/- 27 U/l. Kallikrein-inhibiting concentrations of aprotinin did not influence factor XII. Comparison of the chromogenic with the clotting assay resulted in a correlation coefficient of r = 0.831 (p-value less than 0.001). In patients with deep vein thrombosis, factor XII level was found to be reduced to about 60% of normal activity.


Related Compounds

Related Articles:

Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.

1981-01-01

[Meth. Enzymol. 80 , 341, (1981)]

Designing of peptide substrates. Different approaches exemplified by new chromogenic substrates for kallikreins and urokinase.

1978-01-01

[Haemostasis 7 , 62, (1978)]

[Determination of factor XII and plasma prekallikrein with chromozym PK].

1982-10-01

[Z. Med. Lab. Diagn. 23(5) , 306-11, (1982)]

[Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].

1982-01-01

[Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 109(1) , 115-20, (1982)]

Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.

1992-03-17

[Biochem. Pharmacol. 43(6) , 1361-9, (1992)]

More Articles...